The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center

Cancer Policy

NIH’s Bhattacharya acknowledges absence of causal link between vaccines and autism

White House launches TrumpRx website

“Basic Experimental Studies Involving Humans” no longer classified as clinical trials at NIH in an effort to reduce administrative burden

FDA debuts precheck manufacturing program to boost domestic drug development

NIH suspends new embryonic stem cell line submissions

CMS to enter negotiations with drugmakers over the price of four cancer medications

Clinical Roundup

NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer

Neoadjuvant pembrolizumab helps shrink tumors in patients with desmoplastic melanoma

Oxybutynin reduces hot flashes during prostate cancer treatment, randomized study finds

Oral cancer pain and opioid tolerance share underlying process, study finds

Researchers build best practice framework to boost racial and cultural diversity in biospecimen research

Researchers create blueprint for designing CD8 killer T cells to kill cancer cells

In The Clinic
Trials & Tribulations

Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore

News Analysis
Health Equity
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account